AI-Driven In Silico R&D Services: Drug Discovery, Off-Target Prediction, and Medical Image Analysis Outsourcing

Advanced Computational R&D Outsourcing Services

Yılmaz Bilişim offers high-value, turn-key computational services to pharmaceutical companies, biotech startups, and research institutions seeking to accelerate their development cycles and reduce experimental costs. Our services leverage deep academic expertise and proprietary algorithms.

Computational Drug Discovery Services

We manage the entire in silico workflow for drug design and safety assessment:

• Toxicity & Safety Profiling: Off-target prediction modeling using machine learning to identify potential side effects and polypharmacology profiles early.

• Virtual Screening & Docking: High-throughput screening of large compound libraries against specific biological targets.

• Molecular Dynamics (MD) Simulations: Advanced analysis of target-ligand stability and binding mechanisms.

• Drug Repurposing: Identifying new potential uses for existing molecules based on computational modeling.

Medical Image Analysis & Diagnostics

We develop and deploy custom Deep Learning models for advanced diagnostic support:

• Classification & Segmentation: Developing high-accuracy models for classifying and segmenting anomalies in various medical images (e.g., CBCT, Dermoscopy, X-Ray).

• Custom Model Development: Training tailored AI solutions for specific clinical needs or rare disease identification based on visual data.

Engineering & Software Development

We offer contract services for bridging complex algorithms into reliable commercial software and engineering solutions:

• Integrating our AI models into existing client platforms.

• Custom software development for simulation and data processing.

We are actively seeking service contracts and long-term retainer agreements.